|
Mar, 2010 | Pages : 60 | Price : US$ 800.00 |
| The pharmaceutical market and medical devices market are projected to grow at a CAGR of around 10% and 12% respectively during 2010-2012. |
| |
|
Mar, 2010 | Pages : 75 | Price : US$ 1000.00 |
| The healthcare industry is expected to sustain its growth pace in near future owing to the burden of diseases and poor demographic conditions which will create demand for better healthcare facilities. |
| |
|
Feb, 2010 | Pages : 25 | Price : US$ 500.00 |
| The UAE diabetes care market is projected to grow at a CAGR of more than 8% during 2010-2012. Also, the demand for blood glucose meters and other medical devices will increase at a rapid pace. |
| |
|
Feb, 2010 | Pages : 95 | Price : US$ 1100.00 |
| The Pharma industry is emerging as one of the leading sectors in the healthcare industry, showing an unprecedented growth of around 21% to generate revenue of about US$ 22.2 Billion in 2009. |
| |
|
Jan, 2010 | Pages : 40 | Price : US$ 800.00 |
| Although the market is currently dominated by local and unorganized players, the organized segment has also reported strong growth. The services are projected to grow at a CAGR of more than 20%. |
| |
|
Jan, 2010 | Pages : 85 | Price : US$ 1000.00 |
| It is expected that Indian healthcare market will grow at a CAGR of around 21% during 2010-2013. |
| |
|
Dec, 2009 | Pages : 45 | Price : US$ 1000.00 |
| With continuous increase in demand, the industry is expected to witness growth of around 8% in 2009 over the previous year. |
| |
|
Dec, 2009 | Pages : 130 | Price : US$ 1500.00 |
| The pharmaceutical market in the above mentioned emerging countries is projected to grow at a CAGR of around 14.7% during 2009-2012. |
| |
|
Dec, 2009 | Pages : 105 | Price : US$ 1600.00 |
| The global IVD market is forecast to grow at a CAGR of around 9% during 2010-2012. The market is particularly characterized by the emergence of various novel technologies. |
| |
|
Dec, 2009 | Pages : 170 | Price : US$ 1800.00 |
| The global pharma industry is projected to grow at a CAGR of around 6% during 2010-2012. The growth will be driven by low cost factor. |
| |
|
|
